SBI Securities’s AYTU BioPharma AYTU Stock Holding History

SBI Securities’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22	Sell	10 -1	-9%	-$2	﹤0.01%	3824
2026 Q1	$30	Hold	11	–	–	﹤0.01%	3678
2025 Q4	$29	Sell	11 -51	-82%	-$114	﹤0.01%	3699
2025 Q3	$117	Sell	62 -149	-71%	-$344	﹤0.01%	3473
2025 Q2	$460	Buy	211 +150	+246%	+$233	﹤0.01%	2998
2025 Q1	$73	Hold	61	–	–	﹤0.01%	3546
2024 Q4	$104	Buy	+61	New	+$111	﹤0.01%	3443

Other funds holding AYTU

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

VFM

Vision Financial Markets Stamford, Connecticut $115M AUM 18.96% 1-Year Est. Return

SBI Securities's AYTU Position: Q2 2026 in Review

SBI Securities reduced its AYTU BioPharma (AYTU) stake by 9.1% in Q2 2026, selling an estimated $2 and leaving 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

SBI Securities first reported a position in AYTU in Q4 2024 and has held it in 7 quarters since. The position peaked at $460 in Q2 2025. 5 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

SBI Securities held 10 shares of AYTU BioPharma worth $22 as of Q2 2026.
SBI Securities sold 1 AYTU BioPharma share in Q2 2026, an estimated $2.
AYTU BioPharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3824 holding.
SBI Securities first reported a position in AYTU BioPharma in Q4 2024 and has held it in 7 quarters since.
SBI Securities's AYTU BioPharma position peaked at $460 in Q2 2025.
5 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.